Arthur Allen

Visit kff.org to read Arthur's bio.

aallen@kff.org
@ArthurAllen202

Why the CDC Has Recommended New Covid Boosters for All

As covid-19 hospitalizations tick upward with fall approaching, the CDC says it’s time for new boosters — and not only for those at highest risk of serious disease. Here are seven things you need to know.

The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers

The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer’s, experts say.